Alpha-thalassemia

Alpha‑thalassemia is caused by missing or altered alpha‑globin genes that lower hemoglobin levels. Some risks are written in our DNA, passed down through families. It is usually inherited from parents who carry the trait, and two carrier parents have a higher chance of a child with severe disease. Risk is higher in people with Southeast Asian, Chinese, Indian, Middle Eastern, African, or Mediterranean ancestry. Illness, pregnancy, low folate, or some medicines can worsen anemia, and screening can help before early symptoms of alpha‑thalassemia appear.

Genetic risk factors

Genetic risk factors for alpha-thalassemia mostly involve changes in the two alpha‑globin genes (HBA1 and HBA2) that reduce how much alpha‑globin is made. These changes include missing segments of DNA (deletions) and smaller variants that weaken gene function, and the combined effect depends on how many gene copies are affected. Family origins from regions with higher carrier rates and having a partner who is a carrier increase the chance of passing alpha‑thalassemia to a child. Carrying a genetic change doesn’t guarantee the condition will appear.

• Gene deletions: Missing segments in the alpha‑globin genes are the most common cause. These deletions lower or shut off alpha‑globin production. The impact varies with the size and location of the deletion.

• Non-deletion variants: Some people inherit small changes in the alpha‑globin genes that weaken how the gene works. These can cause the disorder on their own or make it worse when combined with a deletion. Variants like Constant Spring are often linked to more severe anemia.

• Gene copy number: Each person usually has four alpha‑globin gene copies. Losing one, two, three, or four copies leads to a spectrum from silent carrier to severe alpha-thalassemia. More missing copies generally mean more severe symptoms.

• Cis vs trans: Two missing copies on the same chromosome, called cis, carry different reproductive risks than one missing on each chromosome, called trans. Cis deletions raise the chance of a future child with severe alpha‑thalassemia if the other partner is also a carrier. Knowing the arrangement helps doctors estimate risks for your family.

• Recessive inheritance: Alpha‑thalassemia follows an autosomal recessive pattern. A child is at risk for more serious forms when changes are inherited from both parents. If only one parent carries a change, the child is usually just a carrier.

• Carrier couple risk: When both partners carry alpha‑globin gene changes, each pregnancy has a set chance of severe disease. Depending on the exact changes, the chance of a child with HbH disease or hydrops fetalis can be up to 25% per pregnancy. Genetic counseling can clarify the specific numbers for your family.

• Ancestry patterns: Carrier rates are higher among people with Southeast Asian, Southern Chinese, Mediterranean, Middle Eastern, African, or South Asian ancestry. This makes alpha‑thalassemia more common in these populations. Family origins can guide whether carrier screening is offered before or during pregnancy.

• Related parents: Parents who are blood relatives are more likely to share the same alpha‑globin change. This increases the chance that a child inherits changes from both sides and develops the condition. The exact risk still depends on each parent’s specific genes.

• De novo changes: Occasionally, an alpha‑globin gene change appears for the first time in a child. In these cases, parental testing may show neither parent is a carrier. A genetics specialist can explain what this means for future pregnancies.

• Other hemoglobin genes: Changes in other hemoglobin genes can modify how red blood cell problems show up. Pairing an alpha‑globin change with certain structural hemoglobin variants may shift anemia severity. Comprehensive testing helps outline the full genetic picture.

Transmission

Alpha-thalassemia is not contagious; you cannot catch it from someone or spread it through everyday contact, coughing, sex, or shared items. Instead, alpha-thalassemia is passed down in families through autosomal recessive inheritance, meaning gene changes are carried by parents and can be passed to children. How alpha-thalassemia is inherited—and how severe it is—depends on how many of the four alpha‑globin gene copies are affected. If both parents are carriers, each pregnancy has a chance of a child with alpha-thalassemia, ranging from a silent carrier state to more serious forms. New, spontaneous changes can happen but are uncommon; most cases come from genetic transmission of alpha-thalassemia within a family.

When to test your genes

Alpha-thalassemia is a genetic condition, so consider testing if you have unexplained anemia, small red blood cells, or a family history of thalassemia or Mediterranean, African, Middle Eastern, or Southeast Asian ancestry. Test before pregnancy or early in pregnancy to guide partner testing and newborn planning. Test to tailor transfusions, iron decisions, and long-term care.

Managing day-to-day energy is a common focus for people with Alpha-thalassemia, especially if anemia causes fatigue, shortness of breath on stairs, or headaches after a busy day. The outlook is not the same for everyone, but mild forms (often called silent carrier or trait) usually have a normal life expectancy and little to no impact on daily life. Those with moderate anemia may need occasional transfusions, iron checks to avoid overload, and extra planning for pregnancy or surgery. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.

Looking at the long-term picture can be helpful. People with Alpha-thalassemia intermedia (Hemoglobin H disease) often do well into adulthood but may face complications such as gallstones, spleen enlargement, bone changes, and iron overload—sometimes even without many transfusions. Careful monitoring and treatment of early symptoms of Alpha-thalassemia, like worsening fatigue or new jaundice, can prevent hospital visits and protect the heart and liver over time. With ongoing care, many people maintain steady work, exercise, and family life.

For the most severe form (often called alpha-thalassemia major), outcomes depend on early diagnosis and access to specialized care. Without treatment in pregnancy, this form can be life-threatening to the fetus and risky for the pregnant parent; with expert care, options like in‑utero transfusions and planned deliveries have improved survival into infancy and beyond, though intensive ongoing transfusions and chelation are usually needed. Stem cell transplant can be curative for some children, but it carries short- and long-term risks and isn’t right for everyone. Talk with your doctor about what your personal outlook might look like.

Alpha-thalassemia treatment focuses on how severe the anemia is and what symptoms are present. Mild alpha-thalassemia often needs no specific treatment beyond routine checkups, folic acid, and avoiding excess iron unless iron deficiency is proven with tests. Moderate to severe alpha-thalassemia may require occasional or regular blood transfusions, usually with iron chelation medicines to prevent iron overload from repeated transfusions; a doctor may adjust your dose to balance benefits and side effects. In the most severe form, some children are considered for bone marrow (stem cell) transplant, and during pregnancy, specialized care is needed for both parent and baby. Alongside medical treatment, lifestyle choices play a role, including staying up to date with vaccines, promptly treating infections, and checking with your care team before taking supplements; ask your doctor about the best starting point for you.

Alpha-thalassemia runs in families because it stems from changes in the genes that help your body make hemoglobin, the oxygen-carrying protein in red blood cells. A “carrier” means you hold the gene change but may not show symptoms. Most people have four working copies of the alpha-globin gene; the more copies that are missing, the higher the chance of anemia and other problems.

Which gene changes you inherit from your parents can also influence whether early symptoms of Alpha-thalassemia appear at birth, in childhood, or much later. When two carriers have a baby, there’s a risk of a more severe form, especially if both missing copies sit on the same chromosome—a pattern seen more often in some Southeast Asian families. Blood and genetic tests can confirm Alpha-thalassemia carrier status, explain family patterns, and support planning for pregnancy and care.

When iron deficiency occurs alongside Alpha-thalassemia, tiredness and shortness of breath may feel worse, and early symptoms of Alpha-thalassemia can look a lot like low iron, which makes diagnosis and treatment choices more complex. Doctors call it a “comorbidity” when two conditions occur together. Having Alpha-thalassemia together with sickle cell disease or beta-thalassemia can change how each condition behaves: it may ease some complications by reducing very fragile red cells, yet in some people it can also thicken the blood slightly, so care teams watch for clots or pain crises. If someone also has G6PD deficiency, certain infections or medicines that cause oxidative stress can trigger more rapid red blood cell breakdown and a sharper drop in hemoglobin. Viral illnesses that temporarily shut down red blood cell production—most famously a common childhood virus—can cause sudden, severe anemia in people with Alpha-thalassemia, especially those who already run low. Frequent transfusions raise iron levels; if liver disease or hereditary iron overload is also present, the risk of iron buildup in organs increases, so coordinated monitoring and treatment plans are important.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.